Cargando…

Preventing the clinical manifestations and disease progression of coronavirus disease using clinically proven protease inhibitors

Detalles Bibliográficos
Autores principales:	Sagawa, Tomoya, Inoue, Ken-ichiro, Takano, Hirohisa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7432454/ https://www.ncbi.nlm.nih.gov/pubmed/32811550 http://dx.doi.org/10.1186/s13054-020-03235-4

Ejemplares similares

Use of protease inhibitors for the prevention of COVID-19
por: Sagawa, Tomoya, et al.
Publicado: (2020)

Role of IL-6 in Severe Inflammation
por: Inoue, Ken-ichiro, et al.
Publicado: (2021)

COVID-19 and Coagulopathy
por: Inoue, Ken-ichiro, et al.
Publicado: (2021)

Extensive Analysis of Elastase-Induced Pulmonary Emphysema in Rats: ALP in the Lung, a New Biomarker for Disease Progression?
por: Inoue, Ken-ichiro, et al.
Publicado: (2010)

Components of Diesel Exhaust Particles Diversely Enhance a Variety of Respiratory Diseases Related to Infection or Allergy: Extracted Organic Chemicals and the Residual Particles after Extraction Differently Affect Respiratory Diseases
por: Takano, Hirohisa, et al.
Publicado: (2007)

Protective Effects of Urinary Trypsin Inhibitor on Systemic Inflammatory Response Induced by Lipopolysaccharide
por: Inoue, Ken-ichiro, et al.
Publicado: (2008)

Clinical Manifestations of Coronavirus Disease 2019
por: Kutsuna, Satoshi
Publicado: (2021)

Authors' Reply to Comments from Dr. Guan
por: Inoue, Ken-ichiro, et al.
Publicado: (2009)

Particulate Matter–Induced Health Effects: Who Is Susceptible?
por: Inoue, Ken-ichiro, et al.
Publicado: (2011)

Aggravating Impact of Nanoparticles on Immune-Mediated Pulmonary Inflammation
por: Inoue, Ken-Ichiro, et al.
Publicado: (2011)

Environmental pollution and allergies
por: Takano, Hirohisa, et al.
Publicado: (2017)

Coronavirus Disease-2019 Pneumonia: Clinical Manifestations
por: Sharifi, Husham, et al.
Publicado: (2023)

Recent progress in the discovery of inhibitors targeting coronavirus proteases
por: Wang, Haofeng, et al.
Publicado: (2016)

Florid Nonmotor Manifestations of a Pathologically proven Progressive Supranuclear Palsy
por: Shin, Chaewon, et al.
Publicado: (2018)

Erratum: Florid Nonmotor Manifestations of a Pathologically proven Progressive Supranuclear Palsy
Publicado: (2019)

Coronavirus Disease 2019 and Stroke: Clinical Manifestations and Pathophysiological Insights
por: Divani, Afshin A., et al.
Publicado: (2020)

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
por: Hoffmann, Markus, et al.
Publicado: (2020)

Coronavirus enzyme inhibitors-experimentally proven natural compounds from plants
por: Park, Junsoo, et al.
Publicado: (2022)

Clinical Findings in Four Siblings with Genetically Proven Oguchi Disease
por: Ilhan, Cagri, et al.
Publicado: (2020)

Cardiac manifestations of the coronavirus disease-19: a review of pathogenesis, clinical manifestations, diagnosis, and treatment
por: Khalid, Momina, et al.
Publicado: (2021)

Reversal of the Progression of Fatal Coronavirus Infection in Cats by a Broad-Spectrum Coronavirus Protease Inhibitor
por: Kim, Yunjeong, et al.
Publicado: (2016)

Impact of Diesel Exhaust Particles on Th2 Response in the Lung in Asthmatic Mice
por: Inoue, Ken-ichiro, et al.
Publicado: (2008)

Metallothionein as an Anti-Inflammatory Mediator
por: Inoue, Ken-ichiro, et al.
Publicado: (2009)

Biological Response-Enhancing Activity with Antigens in A549 Cells Exposed to Representative Polycyclic Aromatic Hydrocarbons
por: Misaki, Kentaro, et al.
Publicado: (2021)

Ocular disease awareness and pattern of ocular manifestation in patients with biopsy-proven lung sarcoidosis
por: Pefkianaki, Maria, et al.
Publicado: (2011)

Pathogenesis, clinical manifestations and complications of coronavirus disease 2019 (COVID-19)
por: Kordzadeh-Kermani, Elaheh, et al.
Publicado: (2020)

Cutaneous manifestations in patients with coronavirus disease 2019: clinical and histological findings()()
por: Fattori, Antonin, et al.
Publicado: (2021)

Hepatic manifestations of coronavirus disease 2019 infection: Clinical and laboratory perspective
por: Hanif, Farina M, et al.
Publicado: (2022)

Preventing aggressive prostate cancer with proven cardiovascular disease preventive methods
por: Moyad, Mark A
Publicado: (2015)

Commentary: SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
por: Djomkam, Alexandra Lindsey Zune, et al.
Publicado: (2020)

Association of RASis and HMG-CoA reductase inhibitors with clinical manifestations in coronavirus disease 2019 patients: Results from the Khorshid Coronavirus Disease Cohort Study
por: Iraj, Bijan, et al.
Publicado: (2023)

Role of salivary leukocyte protease inhibitor in periodontal disease progression
por: Pateel, Deepak, et al.
Publicado: (2010)

Ocular Manifestations of Biopsy-Proven Pulmonary Sarcoidosis in Korea
por: Choi, Seung Yong, et al.
Publicado: (2018)

Correction: Reversal of the Progression of Fatal Coronavirus Infection in Cats by a Broad-Spectrum Coronavirus Protease Inhibitor
por: Kim, Yunjeong, et al.
Publicado: (2016)

Connected speech as a marker of disease progression in autopsy-proven Alzheimer’s disease
por: Ahmed, Samrah, et al.
Publicado: (2013)

Coronavirus Disease 2019: Clinics, Treatment, and Prevention
por: Burkert, Francesco Robert, et al.
Publicado: (2021)

The Clinical and Radiological Manifestations in Coronavirus Disease 2019 With Negative Nucleic Acid Results
por: Lang, Guanjing, et al.
Publicado: (2020)

Protease inhibitors targeting coronavirus and filovirus entry
por: Zhou, Yanchen, et al.
Publicado: (2015)

“Clinical Profile of Genetically Proven Huntington's Disease Patients from Eastern India”
por: Hussain, Zakir, et al.
Publicado: (2020)

Gastrointestinal manifestations in patients with coronavirus disease-2019 (COVID-19): Impact on clinical outcomes
por: Tabesh, Elham, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_54k5d537kqu2i7tc5lqr45696k